These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31562676)

  • 1. Comparison of chemical extraction methods for determination of 146S content in foot-and-mouth disease oil-adjuvanted vaccine.
    Saravanan P; Iqbal Z; Selvaraj DPR; Aparna M; Umapathi V; Krishnaswamy N; Tamilselvan RP
    J Appl Microbiol; 2020 Jan; 128(1):65-73. PubMed ID: 31562676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Detection of the Foot-And-Mouth Disease Virus Serotype O 146S Antigen for Vaccine Production Using a Double-Antibody Sandwich ELISA and Nonlinear Standard Curves.
    Feng X; Ma JW; Sun SQ; Guo HC; Yang YM; Jin Y; Zhou GQ; He JJ; Guo JH; Qi SY; Lin M; Cai H; Liu XT
    PLoS One; 2016; 11(3):e0149569. PubMed ID: 26930597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Modulatory Potential of Anti-idiotype Antibodies as a Surrogate of Foot-and-Mouth Disease Virus Antigen.
    Naveed A; Rahman SU; Arshad MI; Aslam B
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30333183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant effect of saponin in an oil-based monovalent (serotype O) foot-and-mouth disease virus vaccine on the antibody response in guinea pigs and cattle.
    Bazid AI; El-Alfy HA; El-Didamony G; Elfeil WK; El-Sayed MM; Fawzy M
    Arch Virol; 2021 Jul; 166(7):1977-1984. PubMed ID: 33871696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
    Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No significant differences in the breadth of the foot-and-mouth disease serotype A vaccine induced antibody responses in cattle, using different adjuvants, mixed antigens and different routes of administration.
    Tekleghiorghis T; Weerdmeester K; van Hemert-Kluitenberg F; Moormann RJ; Dekker A
    Vaccine; 2014 Sep; 32(41):5330-6. PubMed ID: 25092634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Using size-exclusion chromatography to quantify the 146S antigen in inactivated foot-and-mouth disease vaccine].
    Xu Y; Zou X; Li C; Zhu Y; He T; Yang Y; Lin X; Song Y; Zheng J; Zhang S; Zhao Q
    Sheng Wu Gong Cheng Xue Bao; 2018 May; 34(5):676-684. PubMed ID: 29893075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cell density on the biological titer and yield of 146S fraction of foot-and-mouth disease virus O in cell suspension.
    Rizvi A; Hussain N; Anjum AA; Ahmed N; Naeem A; Khan M; Altaf I
    J Virol Methods; 2022 Feb; 300():114379. PubMed ID: 34826516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the optimal method for the concentration and purification of 146S particles for foot-and-mouth disease vaccine production.
    Kim H; Kim AY; Kim JS; Lee JM; Kwon M; Bae S; Kim B; Park JW; Park CK; Ko YJ
    J Virol Methods; 2019 Jul; 269():26-29. PubMed ID: 30974178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Heparin Affinity Chromatography to Produce a Differential Vaccine without Eliciting Antibodies against the Nonstructural Proteins of the Serotype O Foot-and-Mouth Disease Viruses.
    Park SY; Lee JM; Kim AY; Park SH; Kim JS; Kim H; Park JW; Park JH; Ko YJ; Park CK
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33297420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of intact 146S foot-and-mouth disease antigen for vaccine production by a double antibody sandwich ELISA using monoclonal antibodies.
    Van Maanen C; Terpstra C
    Biologicals; 1990 Oct; 18(4):315-9. PubMed ID: 2178351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective immune response to liposome adjuvanted high potency foot-and-mouth disease vaccine in Indian cattle.
    Saravanan P; Sreenivasa BP; Selvan RP; Basagoudanavar SH; Hosamani M; Reddy ND; Nathanielsz J; Derozier C; Venkataramanan R
    Vaccine; 2015 Jan; 33(5):670-7. PubMed ID: 25528522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vaccine pretreatment for quantification of 146S antigen in foot-and-mouth disease vaccines by high performance size exclusion chromatography].
    Song Y; Yang Y; Su Z; Liu L; Zhu Y; Xu Y; Zou X; Zhao Q; Zhang S
    Sheng Wu Gong Cheng Xue Bao; 2019 Aug; 35(8):1441-1452. PubMed ID: 31441615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xylaria hypoxylon Lectin as Adjuvant Elicited Tfh Cell Responses.
    Kang J; Zuo Y; Guo Q; Wang H; Liu Q; Liu Q; Xia G; Kang Y
    Scand J Immunol; 2015 Nov; 82(5):436-42. PubMed ID: 26289530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
    Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
    Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
    Barrera J; Schutta C; Pisano M; Grubman MJ; Brake DA; Miller T; Kamicker BJ; Olutunmbi F; Ettyreddy D; Brough DE; Butman BT; Neilan JG
    Vaccine; 2018 Feb; 36(8):1078-1084. PubMed ID: 29358056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and antigenic relationship of foot-and-mouth disease virus serotype O isolates with the vaccine strain O1/BFS.
    Xu W; Zhang Z; Nfon C; Yang M
    Vaccine; 2018 Jun; 36(26):3802-3808. PubMed ID: 29776753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design and efficacy of a multi-epitope recombinant protein vaccine against foot-and-mouth disease virus serotype A in pigs.
    Cao Y; Li D; Fu Y; Bai Q; Chen Y; Bai X; Jing Z; Sun P; Bao H; Li P; Zhang J; Ma X; Lu Z; Liu Z
    Antiviral Res; 2017 Apr; 140():133-141. PubMed ID: 28161579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foot-and-mouth disease vaccine potency testing: the influence of serotype, type of adjuvant, valency, fractionation method, and virus culture on the dose-response curve in cattle.
    Jamal SM; Bouma A; van den Broek J; Stegeman A; Chénard G; Dekker A
    Vaccine; 2008 Nov; 26(50):6317-21. PubMed ID: 18822336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.
    Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
    Vaccine; 2006 Apr; 24(16):3184-90. PubMed ID: 16488060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.